Cancer vaccine
A vaccine effective against human papillomaviruses (HPV), which are thought responsible for most cases of cervical and anal cancers, enters clinical trials in Japan this month. If the trial is successful, the vaccine would be the first used to prevent cancer, claim its developers, a group of researchers from the University of Tokyo and the National Institute of Infectious Diseases reports Japanese newspaper Yomiuri Shimbun. US-based researchers have already tested more than 10 vaccines against specific HPVs but the Japanese vaccine, which targets protein common to all HPVs, is expected to treat every strain.
Related Content
- Order of the Gauhati High Court regarding measures taken by the Assam government to deal with COVID-19, 19/05/2021
- WHO report on cancer- setting priorities, investing wisely & providing care for all
- HPV vaccine can reduce chances of cervical cancer’
- HPV vaccine to be regular, India to be rid of cervical cancer in 60 years: Study
- Sun Pharma gets USFDA nod for cancer treatment injection
- CGC gets Rs 23 lakh grant to develop lung cancer vaccine